​

CME Group Inc.

NasdaqGS:CME Stock Report

Market Cap: US$99.7b

CME Group (CME) Stock Overview

Operates contract markets for the trading of futures and options on futures contracts worldwide. More details

CME fundamental analysis
Snowflake Score
Valuation2/6
Future Growth1/6
Past Performance4/6
Financial Health6/6
Dividends3/6

Rewards

Price-To-Earnings ratio (27.8x) is below the Capital Markets industry average (28.1x)

Earnings are forecast to grow 4.4% per year

Earnings have grown 10.8% per year over the past 5 years

Risk Analysis

Dividend of 3.9% is not well covered by free cash flows

Significant insider selling over the past 3 months


CME Community Fair Values

Create Narrative

See what 47 others think this stock is worth. Follow their fair value or set your own to get alerts.

CME logo
CME Group
AN
AnalystConsensusTarget
Consensus Narrative from 17 Analysts

BrokerTec Chicago And FX Spot+ Will Drive Market Connectivity

Key Takeaways Launches and partnerships, like BrokerTec Chicago and retail trading with Robinhood, are key drivers for revenue growth and market diversification. Product innovation and international expansion in EMEA and APAC are vital for boosting earnings and sustaining demand for CME's risk management products.
View narrative
US$270.17
FV
2.4% overvalued intrinsic discount
4.76%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
28users have followed this narrative
5 days ago author updated this narrative
View CME Group Community

CME Group Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for CME Group
Historical stock prices
Current Share PriceUS$276.70
52 Week HighUS$290.79
52 Week LowUS$193.17
Beta0.46
1 Month Change0.90%
3 Month Change8.50%
1 Year Change41.92%
3 Year Change32.81%
5 Year Change67.49%
Change since IPO3,124.94%

Recent News & Updates

CME Group: Buy Affirmed Again, As Market Demand And Strong Margins Win

Jul 07

Recent updates

CME Group: Buy Affirmed Again, As Market Demand And Strong Margins Win

Jul 07

CME: More Market Volatility Equals More Demands - Initiating With Strong Buy

Apr 27

CME Group At A New All-Time High - Valuation Concerns Justified?

Mar 27

CME Group (NASDAQ:CME) Is Due To Pay A Dividend Of $1.25

Feb 25
CME Group (NASDAQ:CME) Is Due To Pay A Dividend Of $1.25

CME Group: High Quality With Good Dividend Yield

Feb 18

CME Group Inc. (NASDAQ:CME) Just Released Its Annual Results And Analysts Are Updating Their Estimates

Feb 14
CME Group Inc. (NASDAQ:CME) Just Released Its Annual Results And Analysts Are Updating Their Estimates

CME Group's (NASDAQ:CME) Dividend Will Be $1.25

Feb 11
CME Group's (NASDAQ:CME) Dividend Will Be $1.25

CME Group: Exchanges And Data Will Keep Growing, And So Could Its Dividend

Dec 30

CME Group's Dominance Challenged By Now Operational FMX?

Dec 13

CME Group: 5 Reasons Why I Am Bullish

Nov 24

Trade On, Cash In: Why CME Group Is My Pick For Income And Growth

Oct 27

Do CME Group's (NASDAQ:CME) Earnings Warrant Your Attention?

Oct 23
Do CME Group's (NASDAQ:CME) Earnings Warrant Your Attention?

CME Group: An Attractive Business Relatively Out Of Favor

Oct 15

CME Group: An Interesting Option For Every Dividend Investor

Oct 08

CME Group: Poised To Benefit From Rate Cuts; Continues To Innovate

Sep 03

CME Group Has It All - Growth, Dividend Growth, And Value

Aug 26

Down But Not Out: Why CME Group Remains One Of My Favorite Dividend Stocks

Aug 01

CME Group: FMX Market Entry Poses Real Risk

Jul 01

Looking For (Special) Dividends? CME Group Remains One Of My Best Ideas In Finance

May 25

Gunning For CME's Golden Goose

May 01

CME Group: Appealing Business Characteristics That Could Benefit From Geopolitical Uncertainty

Apr 15

CME Group: Improved Valuation Offset By Low Market Volatility And Higher Rates

Mar 27

Shareholder Returns

CMEUS Capital MarketsUS Market
7D0.4%3.1%1.8%
1Y41.9%37.2%13.7%

Return vs Industry: CME exceeded the US Capital Markets industry which returned 37.2% over the past year.

Return vs Market: CME exceeded the US Market which returned 13.7% over the past year.

Price Volatility

Is CME's price volatile compared to industry and market?
CME volatility
CME Average Weekly Movement2.7%
Capital Markets Industry Average Movement4.8%
Market Average Movement7.3%
10% most volatile stocks in US Market17.2%
10% least volatile stocks in US Market3.7%

Stable Share Price: CME has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: CME's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
18983,760Terry Duffywww.cmegroup.com

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services. The company provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services.

CME Group Inc. Fundamentals Summary

How do CME Group's earnings and revenue compare to its market cap?
CME fundamental statistics
Market capUS$99.71b
Earnings (TTM)US$3.58b
Revenue (TTM)US$6.27b
27.8x
P/E Ratio
15.9x
P/S Ratio

Is CME overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CME income statement (TTM)
RevenueUS$6.27b
Cost of RevenueUS$0
Gross ProfitUS$6.27b
Other ExpensesUS$2.69b
EarningsUS$3.58b

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

Jul 23, 2025

Earnings per share (EPS)9.94
Gross Margin100.00%
Net Profit Margin57.08%
Debt/Equity Ratio12.7%

How did CME perform over the long term?

See historical performance and comparison

Dividends

3.9%
Current Dividend Yield
47%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/07 17:50
End of Day Share Price 2025/07/03 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CME Group Inc. is covered by 39 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Stephen BiggarArgus Research Company
Roger FreemanBarclays
Benjamin BudishBarclays